Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

Open access
Naidoo, Jarushka, Murphy, Catherine, Atkins, Michael B, Brahmer, Julie R, Champiat, Stephane, Feltquate, David, Krug, Lee M, Moslehi, Javid, Pietanza, M Catherine, Riemer, Joanne, Robert, Caroline, Sharon, Elad, Suarez-Almazor, Maria E, Suresh, Karthik, Turner, Michelle, Weber, Jeffrey, Cappelli, Laura C · 2023 · Journal for ImmunoTherapy of Cancer

Abstract

Immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapy may vary substantially in their clinical presentation, including natural history, outcomes to treatment, and patterns. The application of clinical guidelines for irAE management can be challenging for practitioners due to a lack of common or consistently applied terminology. Furthermore, given the growing body of clinical experience and published data on irAEs, there is a greater appreciation for the heterogeneous natural histories, responses to treatment, and patterns of these toxicities, which is not currently reflected in irAE guidelines. Furthermore, there are no prospective trial data to inform the management of the distinct presentations of irAEs. Recognizing a need for uniform terminology for the natural history, response to treatment, and patterns of irAEs, the Society for Immunotherapy of Cancer (SITC) convened a consensus panel composed of leading international experts from academic medicine, industry, and regulatory agencies. Using a modified Delphi consensus process, the expert panel developed clinical definitions for irAE terminology used in the literature, encompassing terms related to irAE natural history (ie, re-emergent, chronic active, chronic inactive, delayed/late onset), response to treatment (ie, steroid unresponsive, steroid dependent), and patterns (ie, multisystem irAEs). SITC developed these definitions to support the adoption of a standardized vocabulary for irAEs, which will have implications for the uniform application of irAE clinical practice guidelines and to enable future irAE clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jitc-2022-006398

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Metadata

Authors
Naidoo, J., Murphy, C., Atkins, M. B., Brahmer, J. R., Champiat, S., Feltquate, D., Krug, L. M., Moslehi, J., Pietanza, M. C., Riemer, J., Robert, C., Sharon, E., Suarez-Almazor, M. E., Suresh, K., Turner, M., Weber, J., & Cappelli, L. C.
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2023-03
Volume
11
Issue
3
Pages
e006398
ISSN
2051-1426 (ISSN-L)
OpenAlex
W4362474345
Cited by
165
References
16
FWCI
17.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. https://app.cochat.ai/papers/10.1136/jitc-2022-006398
The paper
Naidoo, J., Murphy, C., Atkins, M. B., Brahmer, J. R., Champiat, S., Feltquate, D., Krug, L. M., Moslehi, J., Pietanza, M. C., Riemer, J., Robert, C., Sharon, E., Suarez-Almazor, M. E., Suresh, K., Turner, M., Weber, J., & Cappelli, L. C. (2023). Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2022-006398

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.